Selective modification of apoB-100 in the oxidation of low density lipoproteins by myeloperoxidase in vitro

Journal of Lipid Research

Volumn 40, Issue 4, 1999, Pages 686-698

  Yang, Chao Yuh ^a   Gu, Zi Wei ^a   Yang, Manlan ^a   Lin, Shen Nan ^b   Garcia Prats, Anthony J ^a   Rogers, Lynette K ^a   Welty, Stephen E ^a   Smith, Charles V ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

2,4 dinitrophenylhydrazine; ApoB 100; HOCl, hypochlorous acid; LDL, low density lipoproteins; Myeloperoxidase; Oxidized LDL peptides

Indexed keywords

2,4 DINITROPHENYLHYDRAZINE; APOLIPOPROTEIN B100; HYPOCHLOROUS ACID; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE; SULFINIC ACID DERIVATIVE;

ARTICLE; ATHEROSCLEROSIS; ENZYME ACTIVE SITE; HUMAN; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN LIPID INTERACTION;

AMINO ACID SEQUENCE; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUTATHIONE; HUMANS; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; LIPOPROTEINS, LDL; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; PEROXIDASE; PHENYLHYDRAZINES; SULFINIC ACIDS; TRYPSIN;

EID: 0345148809     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witzum. 1989. Beyond cholesterol. Modifications of low density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
2. Steinbrecher, U. P., H. Zhang, and M. Lougheed. 1990. Role of oxidatively modified LDL in atherosclerosis. Free Radical Biol. Med. 9: 155-168.
3. Stocker, R. 1994. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance. Curr. Opin. Lipidol. 5: 422-433.
4. Berliner, J. A., M. Navab, A. M. Fogelman, J. S. Frank, L. L. Demer, P. A. Edwards, A. D. Watson, and A. J. Lusis. 1995. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Cirrulation. 91: 2488-2490.
5. Stadtman, E. R., and B. S. Berlett. 1997. Reactive oxygen-mediated protein oxidation in aging and disease. Chem. Res. Toxicol. 10: 485-494.
6. Dean, R. T., S. Fu, R. Stocker, and M. J. Davies. 1997. Biochemistry and pathology of radical-mediated protein oxidation. Biochem. J. 324: 1-18.
7. Daugherty, A., J. L. Dunn, D. L. Rateri, and J. W. Heinecke. 1994. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94: 437-444.
8. Hazell, L. J., L. Arnold, D. Flowers, G. Waeg, E. Malle, and R. Stocker. 1996. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97: 1535-1544.
9. Hazell, L. J., and R. Stocker. 1993. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem. J. 290: 165-172.
10. Hazell, L. J., J. J. M. van den Berg, and R. Stocker. 1994. Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation. Biochem. J. 302: 297-304.
11. Hazen, S. L., and J. W. Heinecke. 1997. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99: 2075-2081.
12. Yang, C-Y., Z-W. Gu, H-X. Yang, A. M. Gotto, Jr., and C. V. Smith. 1997. Oxidative modifications of apoB-100 by exposure of low density lipoproteins to HOCl in vitro. Free Radical Biol. Med. 23: 82-89.
13. Barany, G., and R. B. Merrifield. 1980. Solid phase peptide synthesis. In The Peptides: Analysis, Synthesis, Biology. E. Gross and J. Meienhofer, editors. Academic Press, New York. 3-284.
14. Jayatilleke, E., and S. Shaw. 1993. A high-performance liquid chromatographic assay for reduced and oxidized glutathione in biological samples. Anal. Biochem. 214: 452-157.
15. Calam, D. H., and S. G. Waley. 1962. Some derivatives of glutathione. Biochem. J. 85: 417-419.
16. Yang, C-Y. Z-W. Gu, S-a. Weng, T. W. Kim, S-H. Chen, H. J. Pownall, P. M. Sharp, S-W. Liu, W-H. Li, A. M. Gotto, Jr., and L. Chan. 1989. Structure of apolipoprotein B-100 of human low density lipoproteins. Arteriosclerosis. 9: 96-108.
17. Hori, H., R. E. Fenna, S. Kimura, and M. Ikeda-Saito. 1994. Aromatic substrate molecules hind at the distal heme pocket of myeloperoxidase. J. Biol. Chem. 269: 8388-8392.
18. Yang, C. Y. T. W. Kim, S. A. Weng, B. Lee, M. Yang, and A. M. Gotto, Jr. 1990. Isolation and characterization of sulfhydryl and disulfide peptides of human apoB-100. Proc. Natl. Acad. Sci. USA. 87: 5523-5527.
19. Marquez, L. A., and H. B. Dunford. 1994. Chlorination of taurine by myeloperoxidase. J. Biol. Chem. 269: 7950-7956.
20. Libby, R. D., T. M. Beachy, and A. K. Phipps. 1996. Quantitating direct chlorine transfer from the enzyme to substrate in chloroperoxidase-catalyzed reactions. J. Biol. Chem. 271: 21820-21827.
21. 2 as enzyme-generated intermediates in chloroperoxidase-catalyzed reactions. J. Biol. Chem. 267: 1769-1775.
22. Nathan, C. F., B. A. Arrick, H. W. Murray, N. M. DeSantis, and Z. A. Cohn. 1980. Tumor cell anti-oxidant defenses. Inhibition of the glutathione redox cycle enhances macrophage-mediated cytolysis. J. Exp. Med. 153: 766-782.
23. Hazen, S. L., F. F. Su, D. M. Mueller, J. R. Crowley, and J. W. Heinecke. 1996. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J. Clin. Invest. 98: 1283-1289.
24. Radi, R., J. S. Beckman, K. M. Bush, and B. A. Freeman. 1991. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266: 4244-4250.
25. DeMaster, E. G., B. J. Quast, B. Redfern, and H. T. Nagasawa. 1995. Reaction of nitric oxide with the free sulfhydryl group of human serum albumin yields a sulfenic acid and nitrous oxide. Biochemistry. 34: 11494-11499.
26. Waldhauser, L., and J. Utrecht. 1991. Oxidation of propylthiouracil to reactive metabolites by activated neutrophils. Implications for agranulocytosis. Drug Metab. Dispos. 19: 354-359.
27. Miller, E. C., and J. A. Miller. 1947. The presence and significance of bound aminoazo dyes in the livers of rats fed p-dimethylaminoazobenzene. Cancer Res. 7: 468-480.
28. Smith C. V., B. H. Lauterburg, and J. R. Mitchell. 1985: Covalent binding and acute lethal injury in vivo: how has the hypothesis survived a decade of critical examination? In Drug Metabolism and Disposition: Considerations in Clinical Pharmacology. G. Wilkinson and M. D. Rawlins, editors. MTP Press, London, 161-181.
29. Nelson, S. D., and P. G. Pearson. 1990. Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals. Annu. Rev. Pharmacol. Toxicol. 30: 169-195.
30. Knight, S. A., C. V. Smith, and S. E. Welty. 1997. Iron and oxidized β-casein in the lavages of hyperoxic Fischer-344 rats. Life Sci. 62: 165-176.
31. Awasthi, S., A. Gyurasics, S. A. Knight, S. E. Welty, and C. V. Smith. 1998. Protein oxidation biomarkers in hyperoxic lung injury in rats: effects of U-74389. Toxicol. Lett. In press.
32. Gotz, M. E., G. A. Kunig, P. Riederer, and M. B. H. Youdim. 1994. Oxidative stress: free radical production in neural degeneration. Pharmacol. Ther. 63: 37-122.
33. Prutz, W. A. 1996. Hypochlorous acid interactions with thiols, nucleotides, DNA, and other biological substrates. Arch. Biochem. Biophys. 332: 110-120.
34. Chesney, J. A., J. W. Eaton, and J. R. Mahoney, Jr. 1996. Bacterial glutathione: a sacrificial defense against chlorine compounds. J. Bacteriol. 178: 2131-2135.
35. Winterbourn, C. C., and S. O. Brennan. 1997. Characterization of the oxidation products of the reaction between reduced glutathione and hypochlorous acid. Biochem. J. 326: 87-92.
36. Grant, A. J., W. Jessup, and R. T. Dean. 1992. Accelerated endocytosis and incomplete catabolism of radical-damaged protein. Biochim. Biophys. Acta. 1134: 203-209.
37. Gupta, S., L. K. Rogers, and C. V. Smith. 1994. Biliary excretion of lysosomal enzymes, iron, and oxidized protein in Fischer-344 and Sprague-Dawley rats and the effects of diquat and acetaminophen. Toxicol. Appl. Pharmacol. 125: 42-50.